Skip to main content
SpringerLink
Log in

Serum CEA levels facilitate detection of recurrences of cancer in patients after gastrectomy

  • Original Articles
  • Published:
The Japanese journal of surgery Aims and scope Submit manuscript

Abstract

In an attempt to assess the usefulness of carcinoembryonic antigen (CEA) for predicting the progression of gastric cancer, CEA productivity was evaluated according to serum CEA levels, at the time of recurrence or relapse. In cases of a recurrence, abnormal CEA levels were observed in 14 of 17 (82.4 per cent) with differentiated carcinoma and in 9 of 21 (42.9 per cent) with undifferentiated carcinoma. Preoperative abnormal CEA levels were observed in only 6 of 41 patients (14.6 per cent). A median lead time of manifestation of recurrence was 5 months. In those with relapse, 9 of 11 (81.8 per cent) patients with differentiated carcinoma and 13 of 18 (72.2 per cent) with an undifferentiated carcinoma had abnormal CEA levels. Preoperative abnormal CEA levels were observed in 24 of these 89 patients (27.0 per cent). Postoperative monitoring of CEA seems to be useful for early recognition of gastric cancer progression, irrespective of the preoperative CEA levels.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Gold P, Freedman SO. Specific carcinoembryonic antigen of the human digestive system. J Exp Med 1965; 122: 467–481.

    Article  PubMed  CAS  Google Scholar 

  2. National Institutes of Health Consensus Development Conference Statement. Carcinoembryonic antigen: Its role as a marker in the management of cancer. Cancer Res 1981; 41: 2017–2018.

    Google Scholar 

  3. Mach JP, Jaeger P, Bertholet MM, Ruegsegger CH, Loosli RM, Pettavel J. Detection of recurrence of large-bowel carcinoma by redioimmunoassay of circulating carcinoembryonic antigen (C.E.A.) Lancet 1974; 2: 535–540.

    Article  PubMed  CAS  Google Scholar 

  4. Martin EW, Kibbey WE, Divecchia L, Anderson G, Catalano P, Minton JP. Carcinoembryonic antigen-clinical and historical aspects. Cancer 1976; 37: 62–81.

    Article  PubMed  Google Scholar 

  5. Steeler Jr G, Zamcheck N, Wilson R, Mayer R, Lokich J, Rau P, Maltz J. Results of CEA-initiated second look surgery for recurrent colorectal cancer. Am J Surg 1980; 139: 544–548.

    Article  Google Scholar 

  6. Zamcheck N. The present status of CEA in diagnosis, prognosis and evaluation of therapy. Cancer 1975; 36: 2460–2468.

    Article  PubMed  CAS  Google Scholar 

  7. Iwamatsu M, Saito T, Matsuguchi T, Tamada R, Soezima K, Inokuchi K. Early detection of recurrence of gastric cancer by serial carcinoembryonic antigen assays. Cellular and Molecular Biology 1980; 26: 287–291.

    PubMed  CAS  Google Scholar 

  8. Tamada R, Hiramoto Y, Abe Y, Nozuka T, Okamura T, Masuda H, Kano T, Inokuchi K. Serial determination of carcinoembryonic antigen for early detection of recurrent gastric cancer. Jpn J Surg 1982; 12: 429–433.

    Article  PubMed  CAS  Google Scholar 

  9. Hirai H. A collaborative clinical study of carcinoembryonic antigen in Japan. Cancer Res 1977; 37: 2267–2274.

    PubMed  CAS  Google Scholar 

  10. Masaki M, Iizuka Y, Morito T, Murai T, Yoshida H, Igarashi T, Kasukawa R, Gonoi T, Yoshida T. Studies on correlation between tumor carcinoembryonic antigen (CEA) content and plasma CEA level in patients with cancer of the stomach and colon. (Jpn J Gastroenterol) 1978; 75: 1911–1923. (in Japanese)

    CAS  Google Scholar 

  11. Zamcheck N, Doos WG, Prudente R, Lurie BB, Gottlieb LS. Prognostic factors in colon carcinoma. —Correlation of serum carcinoembryonic antigen level and tumor histopathology, Human Pathol 1975; 6: 31–45.

    CAS  Google Scholar 

  12. Mach JP, Vienny H, Jaeger P, Haldemann B, Egely R, Pettavel J. Long-term follow-up of colorectal carcinoma patients by repeated CEA radioimmunoassay. Cancer 1978; 42: 1439–1447.

    Article  PubMed  CAS  Google Scholar 

  13. Loewenstein MS, Zamcheck N. Carcinoembryonic antigen (CEA) levels in benign gastrointestinal disease states. Cancer 1978; 42: 1412–1418.

    Article  PubMed  CAS  Google Scholar 

  14. Denk H, Eckerstorrer R, and Holzner. Carcinoembryonic antigen (CEA) in gastrointestinal and extragastrointestinal tumors and its relationship to tumor-cell differentiation. Int J Cancer 1972; 10: 252–272.

    Google Scholar 

  15. Martin F, Martin M.S. Radioimmunoassay of carcinoembryonic antigen in extracts of human colon and stomach. Int J Cancer 1972; 9: 641–647.

    PubMed  CAS  Google Scholar 

  16. Mori T, Wakumoto H, Shimano T, Lee PK, Higashi H. Immunopathological studies on CEA and CEA-associated antigens with reevaluation of the cancer specificities of CEA. Ann N Y Acad of Sci 1975; 259: 412–416.

    CAS  Google Scholar 

  17. Nishida H. Immunohistochemical localization of carcinoembryonic antigen (CEA) in gastric cancer-A comparative study between tissue CEA and plasma CEA-. Nippon Geka Gakkai Zasshi (J Jpn Surg Soci) 1983; 84: 328–335. (in Japanese)

    PubMed  CAS  Google Scholar 

  18. Motoyama H, Watanabe H. Carcinoembryonic antigen production in human gastric cancer cell lines in vitro and in nude mice. GANN 1983; 74: 679–986.

    PubMed  CAS  Google Scholar 

  19. Skarin AT, Delwich R, Zamcheck N, Lokich JJ, Frei E III. Carcinoembryonic antigen: Clinical correlation with chemotherapy for metastatic gastrointestinal cancer. Cancer 1974; 33: 1239–1245.

    Article  PubMed  CAS  Google Scholar 

  20. Mughal AW, Hortobagyi GN, Fritsche HA, Buzdar AU, Yap-HY, Blumenschein GR. Serial plasma carcinoembryonic antigen measurements during treatment of metastatic breast cancer. JAMA 1983; 249: 1881–1886.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Second Department of Surgery, Kyushu University, Faculty of Medicine, Maidashi 3-1-1, 812, Fukuoka, Japan

    Ruuichiro Tamada, Yoichiro Hiramoto, Shunichi Tsujitani, Takashi Nozuka, Takeshi Okamura, Hidetaka Masuda, Keizo Sugimachi & Kiyoshi Inokuchi

Authors
  1. Ruuichiro Tamada
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yoichiro Hiramoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shunichi Tsujitani
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Takashi Nozuka
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Takeshi Okamura
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hidetaka Masuda
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Keizo Sugimachi
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Kiyoshi Inokuchi
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tamada, R., Hiramoto, Y., Tsujitani, S. et al. Serum CEA levels facilitate detection of recurrences of cancer in patients after gastrectomy. The Japanese Journal of Surgery 15, 23–29 (1985). https://doi.org/10.1007/BF02469853

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02469853

Key Words

Search

Navigation